The invention is directed to a novel pharmaceutical composition comprising one or more antifungal agent one or more proteolytic enzyme or water and one or more mucoadhesive agents. The novel composition is advantageously used as antifungal infection particularly due to resistant strains of Candida albicans to azole antifungal agents and biofilm producing strains in immunocompromised and / or normal individuals.